Innoviva Statistics
Total Valuation
Innoviva has a market cap or net worth of $1.13 billion. The enterprise value is $1.39 billion.
Important Dates
The next estimated earnings date is Friday, March 7, 2025, after market close.
| Earnings Date | Mar 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Innoviva has 62.60 million shares outstanding. The number of shares has decreased by -23.51% in one year.
| Current Share Class | 62.60M |
| Shares Outstanding | 62.60M |
| Shares Change (YoY) | -23.51% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 0.89% |
| Owned by Institutions (%) | 95.39% |
| Float | 50.49M |
Valuation Ratios
The trailing PE ratio is 18.25 and the forward PE ratio is 11.09.
| PE Ratio | 18.25 |
| Forward PE | 11.09 |
| PS Ratio | 3.23 |
| Forward PS | 3.24 |
| PB Ratio | 1.69 |
| P/TBV Ratio | 2.57 |
| P/FCF Ratio | 6.97 |
| P/OCF Ratio | 6.96 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 6.30, with an EV/FCF ratio of 8.58.
| EV / Earnings | 21.57 |
| EV / Sales | 3.95 |
| EV / EBITDA | 6.30 |
| EV / EBIT | 7.68 |
| EV / FCF | 8.58 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.78.
| Current Ratio | 1.79 |
| Quick Ratio | 1.57 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | 2.35 |
| Debt / FCF | 3.22 |
| Interest Coverage | 7.75 |
Financial Efficiency
Return on equity (ROE) is 9.97% and return on invested capital (ROIC) is 9.70%.
| Return on Equity (ROE) | 9.97% |
| Return on Assets (ROA) | 9.37% |
| Return on Invested Capital (ROIC) | 9.70% |
| Return on Capital Employed (ROCE) | 17.99% |
| Revenue Per Employee | $3.15M |
| Profits Per Employee | $576,705 |
| Employee Count | 112 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 1.49 |
Taxes
In the past 12 months, Innoviva has paid $9.30 million in taxes.
| Income Tax | 9.30M |
| Effective Tax Rate | 12.59% |
Stock Price Statistics
The stock price has increased by +14.43% in the last 52 weeks. The beta is 0.55, so Innoviva's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +14.43% |
| 50-Day Moving Average | 18.16 |
| 200-Day Moving Average | 18.16 |
| Relative Strength Index (RSI) | 45.13 |
| Average Volume (20 Days) | 436,327 |
Short Selling Information
The latest short interest is 8.81 million, so 14.07% of the outstanding shares have been sold short.
| Short Interest | 8.81M |
| Short Previous Month | 9.81M |
| Short % of Shares Out | 14.07% |
| Short % of Float | 17.45% |
| Short Ratio (days to cover) | 14.77 |
Income Statement
In the last 12 months, Innoviva had revenue of $352.75 million and earned $64.59 million in profits. Earnings per share was $0.99.
| Revenue | 352.75M |
| Gross Profit | 297.14M |
| Operating Income | 181.34M |
| Pretax Income | 153.00M |
| Net Income | 64.59M |
| EBITDA | 221.19M |
| EBIT | 181.34M |
| Earnings Per Share (EPS) | $0.99 |
Full Income StatementBalance Sheet
The company has $260.63 million in cash and $521.96 million in debt, giving a net cash position of -$261.33 million or -$4.17 per share.
| Cash & Cash Equivalents | 260.63M |
| Total Debt | 521.96M |
| Net Cash | -261.33M |
| Net Cash Per Share | -$4.17 |
| Equity (Book Value) | 668.54M |
| Book Value Per Share | 10.68 |
| Working Capital | 176.87M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $162.71 million and capital expenditures -$421,000, giving a free cash flow of $162.29 million.
| Operating Cash Flow | 162.71M |
| Capital Expenditures | -421,000 |
| Free Cash Flow | 162.29M |
| FCF Per Share | $2.59 |
Full Cash Flow StatementMargins
Gross margin is 84.24%, with operating and profit margins of 51.41% and 18.31%.
| Gross Margin | 84.24% |
| Operating Margin | 51.41% |
| Pretax Margin | 20.95% |
| Profit Margin | 18.31% |
| EBITDA Margin | 62.71% |
| EBIT Margin | 51.41% |
| FCF Margin | 46.01% |